ENGINEERED GUANYLATE KINASE VARIANT ENZYMES

    公开(公告)号:US20220325284A1

    公开(公告)日:2022-10-13

    申请号:US17711401

    申请日:2022-04-01

    Applicant: Codexis, Inc.

    Abstract: The present invention provides engineered guanylate kinase (GK) enzymes, polypeptides having GK activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing GK enzymes are also provided. The present invention further provides compositions comprising the GK enzymes and methods of using the engineered GK enzymes. The present invention finds particular use in the production of pharmaceutical compounds.

    ENGINEERED ADENYLATE KINASE VARIANT ENZYMES

    公开(公告)号:US20220325257A1

    公开(公告)日:2022-10-13

    申请号:US17711382

    申请日:2022-04-01

    Applicant: Codexis, Inc.

    Abstract: The present invention provides engineered adenylate kinase (AdK) enzymes, polypeptides having AdK activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing AdK enzymes are also provided. The present invention further provides compositions comprising the AdK enzymes and methods of using the engineered AdK enzymes. The present invention finds particular use in the production of pharmaceutical compounds.

Patent Agency Ranking